Author: Scott, N. A.; Knight, S. B.; Pearmain, L.; Brand, O.; Morgan, D. J.; Jagger, C.; Khan, S.; Hackney, P.; Smith, L.; Menon, M.; Konkel, J.; Shuwa, H. A.; Franklin, M.; Kaestele, V.; Harbach, S.; Brij, S.; Ustianowski, A.; Uriel, A.; Lindergard, G.; Diar Bakerly, N.; Dark, P.; Mathioudakis, A.; Gray, K.; Lord, G.; Felton, T.; Brightling, C.; Ho, L.-P.; NIHR Respiratory TRC,; CIRCO,; Piper Hanley, K.; Simpson, A.; Grainger, J. R.; Hussell, T.; Mann, E. R.
Title: Recovery of monocyte exhaustion is associated with resolution of lung injury in COVID-19 convalescence. Cord-id: n7u0eshq Document date: 2020_10_16
ID: n7u0eshq
Snippet: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection resulting in the clinical syndrome COVID-19 is associated with an exaggerated immune response and monocyte infiltrates in the lungs and other peripheral tissues. It is now increasingly recognised that chronic morbidity persists in some patients. We recently demonstrated profound alterations of monocytes in hospitalised COVID-19 patients. It is currently unclear whether these abnormalities resolve or progress following patient
Document: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection resulting in the clinical syndrome COVID-19 is associated with an exaggerated immune response and monocyte infiltrates in the lungs and other peripheral tissues. It is now increasingly recognised that chronic morbidity persists in some patients. We recently demonstrated profound alterations of monocytes in hospitalised COVID-19 patients. It is currently unclear whether these abnormalities resolve or progress following patient discharge. We show here that blood monocytes in convalescent patients at their 12 week follow up, have a greater propensity to produce pro-inflammatory cytokines TNF and IL-6, which was consistently higher in patients with resolution of lung injury as indicated by a normal chest X-ray and no shortness of breath (a key symptom of lung injury). Furthermore, monocytes from convalescent patients also displayed enhanced levels of molecules involved in leucocyte migration, including chemokine receptor CXCR6, adhesion molecule CD31/PECAM and integrins VLA-4 and LFA-1. Expression of migration molecules on monocytes was also consistently higher in convalescent patients with a normal chest X-ray. These data suggest persistent changes in innate immune function following recovery from COVID-19 and indicate that immune modulating therapies targeting monocytes and leucocyte migration may be useful in recovering COVID-19 patients with persistent symptoms.
Search related documents:
Co phrase search for related documents- abnormal chest and acute admission: 1, 2, 3
- abnormal chest and acute disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
- abnormal chest and acute illness: 1, 2, 3
- abnormal chest and acute infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
- abnormal chest and acute patient: 1
- abnormal chest and acute phase: 1, 2, 3, 4
- abnormal chest and acute sars infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- abnormal chest and admission group: 1, 2
- active disease and acute admission: 1
- active disease and acute disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- active disease and acute illness: 1, 2, 3, 4, 5, 6
- active disease and acute infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
- active disease and acute patient: 1, 2, 3, 4, 5, 6
- active disease and acute phase: 1, 2, 3, 4, 5
- active disease and acute sars infection: 1, 2, 3, 4, 5, 6, 7
- active disease and adhesion molecule: 1, 2
- active disease and admission group: 1, 2
- active sars infection and acute admission: 1
- active sars infection and acute disease: 1, 2, 3, 4, 5, 6
Co phrase search for related documents, hyperlinks ordered by date